Page 29 - HFA Dateline 2022 Special Edition

CURRENT PRODUCTS

How to Navigate Our

Product Charts

The pages that follow contain a comprehensive and exhaustive list of products that are approved by the Food and Drug
Administration for treatment of a bleeding disorder. For ease of navigation, the charts are published in sections by indication
(Factor VIII, Factor IX, Inhibitor, VWD, Rare or Other), with each containing the following categories of information:

Product Half-life
Name used to market and sell the therapy. Amount of time a product stays intact in the bloodstream
until its efficacy is halved.
Manufacturer
Company that produces and sells the therapy. FDA Approved
Year the product was approved for treatment by the FDA.
Product Type
Indicated method used to create product. Indications
Bleeding disorder type/factor deficiency the therapy is
Specific Product Type intended to treat.
Detailed classification of product type, if applicable.

We’ve made every effort to ensure the accuracy of the information in this list by using information directly from
manufacturers and publicly available information from websites such as the FDA’s. We do not encourage community
members to use one product over another, and we strongly urge you to discuss your treatment options with qualified
medical professionals.
Content in this issue is current as of March 2022. Given the fast-paced environment that manufacturers and
governmental agencies work within, some information could have changed since going to print. Please refer to
manufacturers’ or the FDA’s websites for the most up-to-date information.

FIND YOUR SECTION

FACTOR VIII FACTOR IX INHIBITOR VWD OTHER RARE

30 34 36 38 38 40

Special Issue 2022 29
Special Issue 2022 2 9